Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial
Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision label in the page footer updated to v3.5.4, replacing v3.5.3. This change reflects a recent site/template update without altering study information.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page’s displayed revision/version label was updated from v3.5.2 to v3.5.3, indicating a technical UI release rather than a change to the study content.SummaryDifference0.1%

- Check40 days agoChange DetectedThe site revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check62 days agoChange DetectedGlycogen storage disease II was updated to Glycogen storage disease, type II in the page's terminology (MeSH/keywords).SummaryDifference0.1%

- Check69 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to the study details or content.SummaryDifference0.1%

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.